Evidence map›Paper›PMID 39262453›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2024

Prevalence and correlates of oral antibiotic use in Canada.

Glenys Smith, Anna-Louise Crago, Stephanie Alexandre, Denise Gravel-Tropper, Melissa Isada, Braden Knight, Jami Mackenzie, Jayson Shurgold

Abstract read
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Glenys SmithAntimicrobial Resistance Task Force, Public Health Agency of Canada.
Anna-Louise CragoAntimicrobial Resistance Task Force, Public Health Agency of Canada.
Stephanie AlexandreAntimicrobial Resistance Task Force, Public Health Agency of Canada.
Denise Gravel-TropperAntimicrobial Resistance Task Force, Public Health Agency of Canada.
Melissa IsadaAntimicrobial Resistance Task Force, Public Health Agency of Canada.
Braden KnightAntimicrobial Resistance Task Force, Public Health Agency of Canada.
Jami MackenzieAntimicrobial Resistance Task Force, Public Health Agency of Canada.
Jayson ShurgoldAntimicrobial Resistance Task Force, Public Health Agency of Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Antimicrobial use (AMU) is a known driver of antimicrobial resistance. Insight into prevalence and correlates of AMU can help identify health inequities and areas for targeted action. To better understand sociodemographic and medical dimensions of AMU in Canada, the Public Health Agency of Canada, in partnership with Statistics Canada, developed a Rapid Response Module questionnaire on self-reported oral antibiotic use, to be administered as part of the 2018 Canadian Community Health Survey (CCHS). Objective: To provide data on the proportion of people in Canada that self-report the use of antibiotics and sociodemographic and health factors associated with use. Methods: This cross-sectional study used data from the CCHS, a national survey of 24,176 people with a clustered multi-stage stratified random sampling design. In 2018, an antibiotic use module was administered to CCHS participants. Results: Among respondents 18 years and older, 26% reported receipt of at least one oral antibiotic over the past year. Several sociodemographic and health factors had higher adjusted odds of receiving an antibiotic prescription, including those aged 18 years compared to aged 48 years (mean), women compared to men, immigrants compared to non-immigrants (excluding Indigenous), current and former smokers compared to those who have never smoked, and those with comorbidities (asthma, chronic obstructive pulmonary disease, arthritis, heart disease, cancer, bowel disorder and urinary incontinence). Conclusion: Variations in AMU across different key populations and sociodemographic groups highlight the need to improve our understanding of different drivers of AMU and for tailored interventions to reduce inequitable risks of antimicrobial resistance.

Indexed as

antibioticantibiotic resistanceantibiotic useantimicrobial resistanceCanadaCanadian Community Health Survey

Identifiers

PMID39262453
PMCPMC11389847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.